Source: China – South China Morning PostGerman company BioNTech has said it still hopes to have its Covid-19 vaccine approved in China, despite the process having been stalled for months.Approval of the vaccine was “extremely important” but the outcome of China’s regulatory review was “very difficult to predict”, Sean Marett, the firm’s chief commercial officer, was quoted by Reuters as saying at a health care conference on Tuesday.“It is a continued dialogue with the Chinese authorities,” Marett said. “China remains extremely…Read More